The National Science Foundation awarded a $275,000 Project Grant to Oraliva, Inc. under the Technology, Innovation, and Partnerships program to develop a portable, programmable single cell cytology platform for the early detection of epithelial cancers. The platform will combine microfluidics and artificial intelligence to classify potentially cancerous tissue in near real-time through multiparameter single-cell analysis and automated evaluation. The objectives are to link different clinical specimen types to the microfluidics environment and identify biomarkers for oral cavity and other epithelial cancer types. Proof of concept has demonstrated the platform's superior performance for oral cancer detection compared to other diagnostics. Successful completion will enable recognition and assessment of various dysplasia levels across multiple epithelial cancer sites. The award period is February 15, 2023 to January 31, 2024.